LifeStance Health Group Stock Price, News & Analysis (NASDAQ:LFST) $6.69 +0.06 (+0.90%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$6.61▼$6.8750-Day Range$5.21▼$6.8752-Week Range$4.22▼$9.59Volume906,763 shsAverage Volume906,402 shsMarket Capitalization$2.53 billionP/E RatioN/ADividend YieldN/APrice Target$8.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media LifeStance Health Group MarketRank™ Stock AnalysisAnalyst RatingHold2.25 Rating ScoreUpside/Downside23.3% Upside$8.25 Price TargetShort InterestBearish18.64% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.54Based on 6 Articles This WeekInsider TradingSelling Shares$1.99 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.47) to ($0.30) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.52 out of 5 starsMedical Sector857th out of 942 stocksHealth Services Industry10th out of 12 stocks 2.1 Analyst's Opinion Consensus RatingLifeStance Health Group has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $8.25, LifeStance Health Group has a forecasted upside of 23.3% from its current price of $6.69.Amount of Analyst CoverageLifeStance Health Group has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted18.64% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 16.6, which indicates bearish sentiment.Change versus previous monthShort interest in LifeStance Health Group has recently decreased by 2.50%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldLifeStance Health Group does not currently pay a dividend.Dividend GrowthLifeStance Health Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LFST. Previous Next 2.5 News and Social Media Coverage News SentimentLifeStance Health Group has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for LifeStance Health Group this week, compared to 2 articles on an average week.Search Interest1 people have searched for LFST on MarketBeat in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,988,560.00 in company stock.Percentage Held by InsidersOnly 8.50% of the stock of LifeStance Health Group is held by insiders.Percentage Held by Institutions76.98% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for LifeStance Health Group are expected to grow in the coming year, from ($0.47) to ($0.30) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeStance Health Group is -12.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeStance Health Group is -12.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLifeStance Health Group has a P/B Ratio of 1.66. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About LifeStance Health Group Stock (NASDAQ:LFST)LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform, as well as offers patients care virtually through its online delivery platform or in-person at its centers in 33 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.Read More LFST Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LFST Stock News HeadlinesDecember 5, 2023 | finance.yahoo.comInsider Sell Alert: Chief Development Officer Kevin Mullins Sells 113,334 Shares of LifeStance ...December 5, 2023 | americanbankingnews.comLifeStance Health Group, Inc. (NASDAQ:LFST) Insider Kevin Michael Mullins Sells 113,334 SharesDecember 9, 2023 | DTI Trader (Ad)All the trading advice you’ve ever received boils down to thisAll the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.December 3, 2023 | americanbankingnews.comLifeStance Health Group (NASDAQ:LFST) Stock Price Down 3.3%November 30, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: UnitedHealth (UNH), Lifestance Health Group (LFST)November 22, 2023 | markets.businessinsider.comGoldman Sachs Maintains Neutral Rating for LifeStance Health Gr: Here's What You Need To KnowNovember 17, 2023 | markets.businessinsider.comROSEN, LEADING INVESTOR COUNSEL, Encourages LifeStance Health Group, Inc. Investors to Inquire About Securities Class Action Investigation - LFSTNovember 12, 2023 | finance.yahoo.comLifeStance Health Group, Inc. (NASDAQ:LFST) Q3 2023 Earnings Call TranscriptDecember 9, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 10, 2023 | finance.yahoo.comInvestors Still Waiting For A Pull Back In LifeStance Health Group, Inc. (NASDAQ:LFST)November 9, 2023 | seekingalpha.comLifeStance Health Group, Inc. 2023 Q3 - Results - Earnings Call PresentationNovember 9, 2023 | markets.businessinsider.comGoldman Sachs Reaffirms Their Hold Rating on Lifestance Health Group (LFST)November 9, 2023 | finance.yahoo.comQ3 2023 Lifestance Health Group Inc Earnings CallNovember 8, 2023 | finance.yahoo.comLifeStance Health Group Inc (LFST) Reports 21% Revenue Growth in Q3 2023 Despite Widening Net LossNovember 7, 2023 | finance.yahoo.comInsider Sell: Kevin Mullins Sells 80,977 Shares of LifeStance Health Group Inc (LFST)November 1, 2023 | benzinga.comROSEN, A LEADING LAW FIRM, Encourages LifeStance Health Group, Inc. Investors to Inquire About Securities Class Action Investigation – LFSTNovember 1, 2023 | finance.yahoo.comWill LifeStance Health Group (LFST) Report Negative Earnings Next Week? What You Should KnowOctober 27, 2023 | benzinga.comInvestigation Into LifeStance Health Group, Inc. (LFST) Announced by Holzer & Holzer, LLCOctober 27, 2023 | finance.yahoo.comMorgan Stanley Predicts at Least 70% Upside for These 2 High-Conviction Stocks — They Have Upcoming Catalysts and Strong Growth ProspectsOctober 25, 2023 | businesswire.comLFST LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages LifeStance Health Group, Inc. Investors With Losses to Inquire About Securities Class Action Investigation – LFSTOctober 23, 2023 | benzinga.comLifeStance Health Group: Company Investigated by the Portnoy Law FirmOctober 18, 2023 | finance.yahoo.comLifeStance to Host Third Quarter 2023 Earnings Conference Call on November 8, 2023October 4, 2023 | forbes.comLifeStance Health Online Therapy ReviewOctober 4, 2023 | finance.yahoo.comInsider Sell: Kevin Mullins Sells 113,333 Shares of LifeStance Health Group Inc (LFST)September 21, 2023 | finance.yahoo.comLifeStance to Present at the 7th Annual Bernstein Healthcare Services Disruptors ConferenceSeptember 6, 2023 | benzinga.comLifeStance Health Gr Recent Insider ActivityAugust 28, 2023 | cnbc.comMorgan Stanley names this little known telehealth stock a top pick, predicts more than 30% upsideSee More Headlines Receive LFST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2023Today12/09/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/13/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Health services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:LFST CUSIPN/A CIK1845257 Webwww.lifestance.com Phone602-767-2100FaxN/AEmployees7,830Year FoundedN/APrice Target and Rating Average Stock Price Target$8.25 High Stock Price Target$9.00 Low Stock Price Target$8.00 Potential Upside/Downside+23.3%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-215,560,000.00 Net Margins-18.72% Pretax Margin-22.10% Return on Equity-12.59% Return on Assets-8.67% Debt Debt-to-Equity Ratio0.17 Current Ratio1.10 Quick Ratio1.10 Sales & Book Value Annual Sales$859.54 million Price / Sales2.95 Cash FlowN/A Price / Cash FlowN/A Book Value$4.04 per share Price / Book1.66Miscellaneous Outstanding Shares378,610,000Free Float346,425,000Market Cap$2.53 billion OptionableNot Optionable Beta1.20 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Kenneth Alan Burdick (Age 64)CEO & Chairman Comp: $624.22kMr. Danish J. Qureshi (Age 38)President & COO Comp: $342.2kMr. David Patrick Bourdon (Age 53)Chief Financial Officer & Treasurer Comp: $368.6kMs. Monica ProkockiVice President of Investor RelationsMr. Ryan Pardo (Age 47)Chief Legal Officer & Secretary Brooke MatthewsDirector of Public RelationsMs. Ann Varanakis (Age 45)Chief People Officer Mr. Pablo Pantaleoni (Age 35)Chief Digital Officer Mr. Kevin Michael Mullins (Age 38)Chief Development Officer Dr. Anisha Patel-Dunn D.O. (Age 47)Chief Medical Officer More ExecutivesKey CompetitorsMagellan HealthNASDAQ:MGLNPrivia Health GroupNASDAQ:PRVAApollo MedicalNASDAQ:AMEH1Life HealthcareNASDAQ:ONEMProgynyNASDAQ:PGNYView All CompetitorsInsiders & InstitutionsKevin Michael MullinsSold 113,334 sharesTotal: $741,204.36 ($6.54/share)Deutsche Bank AGBought 6,597 shares on 11/24/2023Ownership: 0.013%Rock Springs Capital Management LPBought 770,000 shares on 11/15/2023Ownership: 0.969%The Manufacturers Life Insurance Company Bought 14,971 shares on 11/15/2023Ownership: 0.017%Royal Bank of CanadaBought 5,548 shares on 11/15/2023Ownership: 0.012%View All Insider TransactionsView All Institutional Transactions LFST Stock Analysis - Frequently Asked Questions Should I buy or sell LifeStance Health Group stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LifeStance Health Group in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" LFST shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LFST, but not buy additional shares or sell existing shares. View LFST analyst ratings or view top-rated stocks. What is LifeStance Health Group's stock price target for 2024? 4 brokerages have issued twelve-month price objectives for LifeStance Health Group's stock. Their LFST share price targets range from $8.00 to $9.00. On average, they expect the company's share price to reach $8.25 in the next twelve months. This suggests a possible upside of 23.3% from the stock's current price. View analysts price targets for LFST or view top-rated stocks among Wall Street analysts. How have LFST shares performed in 2023? LifeStance Health Group's stock was trading at $4.94 at the beginning of the year. Since then, LFST shares have increased by 35.4% and is now trading at $6.69. View the best growth stocks for 2023 here. When is LifeStance Health Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 13th 2024. View our LFST earnings forecast. How were LifeStance Health Group's earnings last quarter? LifeStance Health Group, Inc. (NASDAQ:LFST) released its quarterly earnings data on Wednesday, November, 8th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.07) by $0.10. The business had revenue of $262.90 million for the quarter, compared to the consensus estimate of $255.18 million. LifeStance Health Group had a negative net margin of 18.72% and a negative trailing twelve-month return on equity of 12.59%. The firm's revenue for the quarter was up 20.8% compared to the same quarter last year. During the same period last year, the company earned ($0.11) earnings per share. What ETFs hold LifeStance Health Group's stock? ETFs with the largest weight of LifeStance Health Group (NASDAQ:LFST) stock in their portfolio include Fidelity Disruptive Medicine ETF (FMED), Global X Telemedicine & Digital Health ETF (EDOC) and First Trust Small Cap Growth AlphaDEX Fund (FYC).iShares U.S. Healthcare Providers ETF (IHF) and What guidance has LifeStance Health Group issued on next quarter's earnings? LifeStance Health Group issued an update on its FY 2023 earnings guidance on Wednesday, November, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.03 billion-$1.04 billion, compared to the consensus revenue estimate of $1.03 billion. When did LifeStance Health Group IPO? (LFST) raised $640 million in an initial public offering (IPO) on Thursday, June 10th 2021. The company issued 40,000,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair served as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are LifeStance Health Group's major shareholders? LifeStance Health Group's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include FMR LLC (7.44%), Brown Advisory Inc. (1.08%), Principal Financial Group Inc. (1.03%), Rock Springs Capital Management LP (0.97%), Jennison Associates LLC (0.54%) and Charles Schwab Investment Management Inc. (0.20%). Insiders that own company stock include Anisha Patel-Dunn, Ann Varanakis, Danish J Qureshi, Gwen H Booth, Jeffrey Crisan, Jesse Michael Bruff, Kenneth T Mills, Kevin Michael Mullins, Michael K Lester, Ryan Pardo, Silversmith Partners I Gp, Llc, Summit Partners Growth Equity and Warren Gouk. View institutional ownership trends. How do I buy shares of LifeStance Health Group? Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:LFST) was last updated on 12/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.